The Reducing REVISITS Study: A Cluster RCT

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Chicago

About this trial

This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via virtual mentored implementation approaches with and without co-design methods.

The investigators will enroll up to 24 randomized sites (with a goal minimum of 16 sites) to:

* Deliver the COPD programs implemented via mentored support in collaboration with SHM Center for Quality Improvement. * Compare the effectiveness and penetration of virtual versus in-person COPD care transition programs implemented along with mentoring support with or without co-design.

The investigators aim to determine which combined approach(es) is/are the most effective at implementing evidence-based COPD program interventions and decreasing COPD acute care revisits with the greatest overall impact and sustainability.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • COPD Transitions of Care Intervention Bundle: Virtual Interventions
  • COPD Transitions of Care Intervention Bundle: In-Person Interventions

Treatment groups

24 Participants
are divided into 4 treatment groups

Sponsors and collaborators

University of Chicago

Lead sponsor

Society of Hospital Medicine

Collaborator

Onda Collective

Collaborator

The Hospital Medicine Reengineering Network (HOMERuN)

Collaborator

COPD Foundation

Collaborator

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator